- Home
- RSF vs CCEL Comparison
RSF vs CCEL Comparison
Compare RSF & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSF
- CCEL
- Stock Information
- Founded
- RSF 2016
- CCEL 1989
- Country
- RSF United States
- CCEL United States
- Employees
- RSF N/A
- CCEL N/A
- Industry
- RSF Investment Managers
- CCEL Managed Health Care
- Sector
- RSF Finance
- CCEL Health Care
- Exchange
- RSF Nasdaq
- CCEL Nasdaq
- Market Cap
- RSF 49.1M
- CCEL 39.9M
- IPO Year
- RSF N/A
- CCEL 1997
- Fundamental
- Price
- RSF $14.56
- CCEL $5.21
- Analyst Decision
- RSF
- CCEL Strong Buy
- Analyst Count
- RSF 0
- CCEL 1
- Target Price
- RSF N/A
- CCEL $8.50
- AVG Volume (30 Days)
- RSF 11.8K
- CCEL 14.8K
- Earning Date
- RSF 01-01-0001
- CCEL 07-14-2025
- Dividend Yield
- RSF 10.61%
- CCEL 19.27%
- EPS Growth
- RSF N/A
- CCEL N/A
- EPS
- RSF N/A
- CCEL 0.01
- Revenue
- RSF N/A
- CCEL $32,102,750.00
- Revenue This Year
- RSF N/A
- CCEL $2.49
- Revenue Next Year
- RSF N/A
- CCEL $0.95
- P/E Ratio
- RSF N/A
- CCEL $321.73
- Revenue Growth
- RSF N/A
- CCEL 2.33
- 52 Week Low
- RSF $14.81
- CCEL $4.75
- 52 Week High
- RSF $16.23
- CCEL $9.43
- Technical
- Relative Strength Index (RSI)
- RSF 33.94
- CCEL 51.22
- Support Level
- RSF $14.58
- CCEL $5.00
- Resistance Level
- RSF $14.73
- CCEL $6.35
- Average True Range (ATR)
- RSF 0.08
- CCEL 0.29
- MACD
- RSF -0.00
- CCEL 0.02
- Stochastic Oscillator
- RSF 8.00
- CCEL 14.07
About RSF RiverNorth Capital and Income Fund
RiverNorth Capital and Income Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income by investing in credit instruments, including a portfolio of securities of specialty finance and other financial companies.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.